Is this your company? Get featured or correct your listing →
Recent changes
- Oct 15, 2026Oct 15, 2026Raised $310M Series C ValueSpectrum
- Oct 15, 2026Oct 15, 2026New investor: Bain Capital Life Sciences ValueSpectrum
- Oct 15, 2026Oct 15, 2026New investor: Forbion ValueSpectrum
- Oct 15, 2026Oct 15, 2026New investor: Northpond Ventures ValueSpectrum
- Oct 15, 2026Oct 15, 2026New investor: Google Ventures (GV) ValueSpectrum
Earlier changes (3)
- Oct 15, 2026Oct 15, 2026New investor: Sanofi Ventures ValueSpectrum
- Oct 15, 2026Oct 15, 2026New investor: British Business Bank ValueSpectrum
- Oct 15, 2026Oct 15, 2026OMass Therapeutics Raises $310M Series C For Rare Disease Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2026 | Series C | $310M | — | Bain Capital Life SciencesLeadunverifiedForbionLeadunverifiedGoogle Ventures (GV)unverifiedNorthpond VenturesunverifiedSanofi VenturesunverifiedBritish Business BankunverifiedNovo Holdings | ValueSpectrum |
Investors
Latest Pulse
- Oct 15, 2026OrbiMed Raises $3B Across Two New Healthcare FundsOrbiMed closed $3 billion across two new vehicles, OrbiMed Private Investments X for US and European life sciences venture capital and OrbiMed Asia Partners VI for Asian healthcare growth equity, bringing the firm's total assets past $21 billion.→
- Oct 15, 2026OMass Therapeutics Raises $310M Series C For Rare DiseaseOxford biotech OMass Therapeutics raised an oversubscribed $310 million Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings to push its lead GPCR drug candidate through Phase 2.→
Coverage Timeline
newest firstAll Coverage
Related Companies
OMass Therapeutics FAQ
Who are OMass Therapeutics's investors?
OMass Therapeutics's investors include Bain Capital Life Sciences, Forbion, British Business Bank, Google Ventures (GV), Northpond Ventures, and 1 more.
Sources & methodologyshow
Where these figures come from
- ValueSpectrumValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.